Bloomios, Inc.
BLMS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 1/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.17 | -0.00 | 8.40 |
| FCF Yield | -50.64% | -3.74% | -11.99% | -0.89% |
| EV / EBITDA | -2.84 | -19.07 | -17.04 | -114.36 |
| Quality | ||||
| ROIC | -19.57% | -80.44% | -174.81% | 3.90% |
| Gross Margin | 36.66% | 44.55% | 30.51% | 0.00% |
| Cash Conversion Ratio | 0.46 | 0.05 | -0.70 | 1.00 |
| Growth | ||||
| Revenue 3-Year CAGR | 66.52% | – | – | – |
| Free Cash Flow Growth | -608.05% | 39.47% | -8,686.46% | -68.63% |
| Safety | ||||
| Net Debt / EBITDA | -1.82 | -1.66 | -2.17 | -2.36 |
| Interest Coverage | -0.53 | -0.52 | -9.86 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 2.17 | 9.19 | 3.13 | 0.00 |
| Cash Conversion Cycle | -22.44 | -131.27 | -570.75 | 0.00 |